Gene · 8647
Papers3,310
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,310
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting E3 ubiquitin ligases and their adaptors as a therapeutic strategy for metabolic diseases. | Exp Mol Med | 2023 | 37779139 | PubTator, text mining | PubMed |
| Featuring molecular regulation of bile acid homeostasis in pediatric short bowel syndrome. | Clin Res Hepatol Gastroenterol | 2023 | 37769812 | PubTator, text mining | PubMed |
| Clinicopathologic Features, Genetics, Treatment, and Long-Term Outcomes in Japanese Children and Young Adults with Benign Recurrent Intrahepatic Cholestasis: A Multicenter Study. | J Clin Med | 2023 | 37762919 | PubTator, text mining | PubMed |
| Misinterpreting Diarrhea-Predominant Irritable Bowel Syndrome and Functional Diarrhea: Pathophysiological Highlights. | J Clin Med | 2023 | 37762728 | PubTator, text mining | PubMed |
| Mild Crigler-Najjar Syndrome with Progressive Liver Disease-A Multicenter Retrospective Cohort Study. | Children (Basel) | 2023 | 37761392 | PubTator, text mining | PubMed |
| Zebrafish as a Useful Model System for Human Liver Disease. | Cells | 2023 | 37759472 | PubTator, text mining | PubMed |
| Immunosuppressive effects of circulating bile acids in human endotoxemia and septic shock: patients with liver failure are at risk. | Crit Care | 2023 | 37759239 | PubTator, text mining | PubMed |
| Management and outcomes after liver transplantation for progressive familial intrahepatic cholestasis: A systematic review and meta-analysis. | Hepatol Commun | 2023 | 37756114 | PubTator, text mining | PubMed |
| Hepatoprotective agents in the management of intrahepatic cholestasis of pregnancy: current knowledge and prospects. | Front Pharmacol | 2023 | 37719856 | PubTator, text mining | PubMed |
| Outcomes of 38 patients with PFIC3: Impact of genotype and of response to ursodeoxycholic acid therapy. | JHEP Rep | 2023 | 37701337 | PubTator, text mining | PubMed |
| Interstitial lung disease and pancreatic exocrine insufficiency in CADDS: Phenotypic expansion and literature review. | JIMD Rep | 2023 | 37701323 | PubTator, text mining | PubMed |
| The Mutational Landscape Of Genetic Cholestatic Diseases In Pakistani Children. | J Pak Med Assoc | 2023 | 37697751 | PubTator, text mining | PubMed |
| Role of Alpha-Fetoprotein (AFP) in Diagnosing Childhood Cancers and Genetic-Related Chronic Diseases. | Cancers (Basel) | 2023 | 37686577 | PubTator, text mining | PubMed |
| Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM. | Int J Mol Sci | 2023 | 37686369 | PubTator, text mining | PubMed |
| Changes in Expression and Function of Placental and Intestinal P-gp and BCRP Transporters during Pregnancy. | Int J Mol Sci | 2023 | 37685897 | PubTator, text mining | PubMed |
| Culture methods focusing on bile canalicular formation using primary human hepatocytes in a short time. | In Vitro Cell Dev Biol Anim | 2023 | 37682508 | PubTator, text mining | PubMed |
| Insights into the Function of Aquaporins in Gastrointestinal Fluid Absorption and Secretion in Health and Disease. | Cells | 2023 | 37681902 | PubTator, text mining | PubMed |
| Expression of circadian regulatory genes is dysregulated by increased cytokine production in mice subjected to concomitant intestinal injury and parenteral nutrition. | PLoS One | 2023 | 37647292 | PubTator, text mining | PubMed |
| Co-consuming green tea with raloxifene decreases raloxifene systemic exposure in healthy adult participants. | Clin Transl Sci | 2023 | 37639334 | PubTator, text mining | PubMed |
| Carvedilol impairs bile acid homeostasis in mice: implication for nonalcoholic steatohepatitis. | Toxicol Sci | 2023 | 37632784 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8647/papers?page=14